KRISTEN BEER: Open Payments
NPI 1053722140 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,898 in 94 payments from 26 companies in 2025. Trend: 2023 $1,424 · 2024 $1,514 · 2025 $1,898
Food & beverage: $1,808Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $274 |
| Daiichi Sankyo Inc. | 11 | $222 |
| Novocure Inc. | 3 | $199 |
| ABBVIE INC. | 10 | $185 |
| TAIHO ONCOLOGY, INC. | 8 | $156 |
| E.R. Squibb & Sons, L.L.C. | 6 | $102 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| Pharmacosmos Therapeutics Inc. | 5 | $92 |
| Stemline Therapeutics Inc. | 4 | $75 |
Products named: Enhertu, Optune Lua (NovoTTF-200T), LONSURF, MONOFERRIC, OJJAARA, VENCLEXTA, Orserdu, IMBRUVICA.
Industry payments across NJ — which companies pay providers there.
